论文信息 - Final Results of the Randomized Phase II NorCap‐CA223 Trial Comparing First‐Line All‐Oral Versus Taxane‐Based Chemotherapy for HER2‐Negative Metastatic Breast Cancer - 字舞流文

Final Results of the Randomized Phase II NorCap‐CA223 Trial Comparing First‐Line All‐Oral Versus Taxane‐Based Chemotherapy for HER2‐Negative Metastatic Breast Cancer

A. Barnadas | A. Chan | Michiel Botha | S. Cinieri | U. Coşkun | N. Tubiana-Mathieu | D. Rauch | A. Vandebroek | G. Villanova | S. Lazzarelli | K. Altundağ | P. Dodyk